CN104327065A - Preparation method of N-methyl(quinolyl-4-yl)methylamine - Google Patents

Preparation method of N-methyl(quinolyl-4-yl)methylamine Download PDF

Info

Publication number
CN104327065A
CN104327065A CN201410464910.5A CN201410464910A CN104327065A CN 104327065 A CN104327065 A CN 104327065A CN 201410464910 A CN201410464910 A CN 201410464910A CN 104327065 A CN104327065 A CN 104327065A
Authority
CN
China
Prior art keywords
compound
reaction
solvent
ring closure
xylol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410464910.5A
Other languages
Chinese (zh)
Inventor
陈芳军
李书耘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Huateng Pharmaceutical Co Ltd
Original Assignee
Hunan Huateng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Huateng Pharmaceutical Co Ltd filed Critical Hunan Huateng Pharmaceutical Co Ltd
Priority to CN201410464910.5A priority Critical patent/CN104327065A/en
Publication of CN104327065A publication Critical patent/CN104327065A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms

Abstract

The invention discloses a preparation method of a thiazole derivative (4-2,3-dihydrobenzo[b][1,4]dioxine-6-yl)thiazole-2-yl)methanol. The method comprises the following steps: carrying out a ring closure reaction on an initial raw material o-diphenol, carrying out a Friedel-Crafts reaction, carrying out a ring closure reaction, carrying out acetal removal protection, and reducing to obtain the target product. The above compound is an important medicine intermediate.

Description

A kind of preparation method of N-methyl-(quinolyl-4) methane amine
Technical field
The present invention relates to a kind of novel processing step of medicine intermediate, particularly a kind of preparation method of a kind of preparation method of (4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazol-2-yl) methyl alcohol.
Technical background
Compound (4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazol-2-yl) methyl alcohol, structural formula is:
This compound (4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazol-2-yl) methyl alcohol and relevant derivative have widespread use in pharmaceutical chemistry and organic synthesis.The synthesis of (4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazol-2-yl) methyl alcohol is comparatively difficult at present.Therefore, need exploitation raw material to be easy to get, easy to operate, reaction is easy to control, the synthetic method that overall yield is suitable.
Summary of the invention
The invention discloses one and prepare (4-(2; 3-dihydrobenzo [b] [1; 4] dioxine-6-base) thiazol-2-yl) method of methyl alcohol; take o-phenol as starting raw material; obtain target product 6 through the ring that reaches a standard, Friedel-Crafts reaction, Guan Huan, the aldehyde protection of de-institute, reduction, synthetic route as shown in Figure 1.Synthesis step is as follows:
(1) o-phenol is starting raw material, obtains 2 through ring closure reaction;
(2) carry out Friedel-Crafts reaction 2, obtain 3;
(3) carry out ring closure reaction 3 and obtain 4;
(4) carry out de-acetal protective reaction 4 and obtain target product 5,
(5) carry out reduction reaction 4 and obtain target product 6,
One preferred embodiment in, the alkali that described ring closure reaction prepares compound 2 used is selected from salt of wormwood; The Lewis acid that described Friedel-Crafts reaction prepares compound 3 used is selected from aluminum chloride; Described ring closure reaction is prepared compound 4 reagent used and is selected from 2,2-diethoxy thioacetamide; The reagent that described de-acetal protective reaction prepares compound 5 used is selected from hydrochloric acid; The reductive agent that described reduction reaction prepares compound 6 used is selected from sodium borohydride.
One preferred embodiment in, the solvent that described ring closure reaction prepares compound 2 used is selected from DMF; The solvent that described Friedel-Crafts reaction prepares compound 3 used is selected from methylene dichloride; The solvent that described ring closure reaction prepares compound 4 used is selected from tetrahydrofuran (THF); The solvent that described de-acetal protective reaction prepares compound 5 used is selected from tetrahydrofuran (THF); Described reduction reaction prepares compound 6 solvent selected from methanol used.
One preferred embodiment in, described ring closure reaction prepares the reflux temperature that compound 2 temperature of reaction used is solvent; Described Friedel-Crafts reaction prepares the reflux temperature that compound 3 temperature used is 0 DEG C ~ solvent; Described ring closure reaction prepares the reflux temperature that compound 4 temperature used is room temperature ~ solvent; Described de-acetal protective reaction prepare compound 5 used be room temperature; Described reduction reaction prepares compound 60 DEG C ~ room temperature used.
The present invention relates to the preparation method of one (4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazol-2-yl) methyl alcohol, there is no other Patents bibliographical informations at present.
Accompanying drawing explanation
Fig. 1 is the synthetic route chart of compound (4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazol-2-yl) methyl alcohol.
The present invention is further described by the following embodiment, and these descriptions are not be further limited content of the present invention.One skilled in the art will understand that the equivalent replacement that technical characteristic of the present invention is done, or improve accordingly, still belong within protection scope of the present invention.
Specific embodiment mode
Embodiment 1
The synthesis of (1) 2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine
42g o-phenol is joined 500ml N, in dinethylformamide, add 51g glycol dibromide, 39g Anhydrous potassium carbonate, reflux stirs 10 hours, the most of DMF of concentrated removing, adds water and ethyl acetate, separatory, drying, concentrated, residuum upper prop is separated and obtains 63g 2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine.
(2) synthesis of the bromo-1-of 2-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) ethane
60g 2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine is joined in 1000ml methylene dichloride, add 27g aluminum chloride, then add 35g 2-bromoacetyl bromide, heated overnight at reflux, be cooled to room temperature, concentrated, then add water, extraction separatory, collect organic phase, separatory, drying, concentrated, on residuum, silicagel column is separated to obtain the bromo-1-(2 of 39g 2-, 3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) ethane.
(3) synthesis of 2-(diethoxymethyl)-4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazole
Bromo-for 35g 2-1-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) ethane is joined in 190ml tetrahydrofuran (THF), add 46g 2 again, 2-diethoxy thioacetamide, stirring at room temperature 1 lab scale, reflux stirs 12 hours, add water and ethyl acetate, filter, extraction separatory, obtains 18g 2-(diethoxymethyl)-4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazole.
(4) synthesis of 4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazole-2-formaldehyde
17g 2-(diethoxymethyl)-4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazole joins in 200ml1N hydrochloric acid, stirring at room temperature 24 hours, add sodium carbonate solution, be adjusted to neutrality, then add extraction into ethyl acetate, separatory, concentrated, on residuum, silicagel column is separated to obtain 11g 4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazole-2-formaldehyde.
(5) synthesis of (4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazol-2-yl) methyl alcohol
10g 4-(2,3-dihydrobenzo [b] [1,4] dioxine-6-base) thiazole-2-formaldehyde joins in 150ml anhydrous methanol, be cooled to 0 DEG C, add 7g sodium borohydride, naturally stirring at room temperature is risen to 18 hours, add saturated ammonium chloride solution, adjust and add extraction into ethyl acetate again, separatory, concentrated, on residuum, silicagel column is separated to obtain 6.8g (4-(2,3-dihydrobenzo [b] [Isosorbide-5-Nitrae] dioxine-6-base) thiazol-2-yl) methyl alcohol.

Claims (6)

1. prepare (4-(2 for one kind; 3-dihydrobenzo [b] [1; 4] dioxine-6-base) thiazol-2-yl) method of methyl alcohol; take o-phenol as starting raw material; obtain target product 6 through the ring that reaches a standard, Friedel-Crafts reaction, Guan Huan, the aldehyde protection of de-institute, reduction, synthetic route is as follows.
2. method according to claim 1, it is characterized by 5 described step reactions is,
(1) o-phenol is starting raw material, obtains 2 through ring closure reaction;
(2) carry out Friedel-Crafts reaction 2, obtain 3;
(3) carry out ring closure reaction 3 and obtain 4;
(4) carry out de-acetal protective reaction 4 and obtain target product 5,
(5) carry out reduction reaction 4 and obtain target product 6,
3. according to the method for claim 1-2, it is characterized in that, described ring closure reaction is prepared compound 2 alkali used and is selected from the mixture of one or more in sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, salt of wormwood, triethylamine, sodium bicarbonate, pyridine, triisopropylamine, saleratus; Described Friedel-Crafts reaction is prepared compound 3 Lewis acid used and is selected from the mixture of one or more in aluminum chloride, iron trichloride, zinc chloride; Described ring closure reaction is prepared compound 4 reagent used and is selected from 2,2-diethoxy thioacetamide; Described de-acetal protective reaction is prepared compound 5 reagent used and is selected from the mixture of one or more in hydrogenchloride, sulfuric acid, hydrochloric acid, tosic acid, trifluoroacetic acid; Described reduction reaction is prepared compound 6 reductive agent used and is selected from the mixture of one or more in sodium borohydride, POTASSIUM BOROHYDRIDE, lithium borohydride, sodium cyanoborohydride, lithium aluminium hydride, borine.
4. according to the method for claim 1-2, it is characterized in that, described ring closure reaction prepares compound 2 solvent selected from methanol used, ethanol, n-propyl alcohol, Virahol, tetrahydrofuran (THF), methylene dichloride, toluene, o-Xylol, p-Xylol, m-xylene, N, the mixture of one or more in dinethylformamide, N,N-dimethylacetamide; Described Friedel-Crafts reaction is prepared compound 3 solvent used and is selected from methylene dichloride, trichloromethane, ethyl acetate, tetrahydrofuran (THF), toluene, tetrahydrofuran (THF), toluene, o-Xylol, p-Xylol, m-xylene, N, the mixture of one or more in dinethylformamide, N,N-dimethylacetamide, water; Described ring closure reaction prepares compound 4 solvent selected from methanol used, ethanol, n-propyl alcohol, Virahol, tetrahydrofuran (THF), methylene dichloride, toluene, o-Xylol, p-Xylol, m-xylene, N, the mixture of one or more in dinethylformamide, N,N-dimethylacetamide, water; Compound 5 solvent selected from methanol used, ethanol, n-propyl alcohol, Virahol, tetrahydrofuran (THF), methylene dichloride, trichloromethane, ethyl acetate, toluene, o-Xylol, p-Xylol, m-xylene, N are prepared in described de-acetal protective reaction, the mixture of one or more in dinethylformamide, N,N-dimethylacetamide; Described reduction reaction prepares compound 6 solvent selected from methanol used, ethanol, n-propyl alcohol, Virahol, tetrahydrofuran (THF), methylene dichloride, trichloromethane, ethyl acetate, toluene, o-Xylol, p-Xylol, m-xylene, N, the mixture of one or more in dinethylformamide, N,N-dimethylacetamide.
5. according to the method for claim 1-2, it is characterized in that, described ring closure reaction prepares the reflux temperature that compound 2 temperature of reaction used is 0 DEG C ~ solvent; Described Friedel-Crafts reaction prepares the reflux temperature that compound 3 temperature used is 0 DEG C ~ solvent; Described ring closure reaction prepares the reflux temperature that compound 4 temperature used is room temperature ~ solvent; Described de-acetal protective reaction prepare compound 5 used be 0 DEG C ~ room temperature; Described reduction reaction prepares compound 60 DEG C ~ room temperature used.
6. according to the method for claim 1-2, it is characterized in that, described ring closure reaction prepares the reflux temperature that compound 2 temperature of reaction used is solvent; Described Friedel-Crafts reaction prepares the reflux temperature that compound 3 temperature used is solvent; Described ring closure reaction prepares the reflux temperature that compound 4 temperature used is solvent; Described de-acetal protective reaction prepare compound 5 used be room temperature; Described reduction reaction prepares compound 60 DEG C ~ room temperature used.
CN201410464910.5A 2014-09-15 2014-09-15 Preparation method of N-methyl(quinolyl-4-yl)methylamine Pending CN104327065A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410464910.5A CN104327065A (en) 2014-09-15 2014-09-15 Preparation method of N-methyl(quinolyl-4-yl)methylamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410464910.5A CN104327065A (en) 2014-09-15 2014-09-15 Preparation method of N-methyl(quinolyl-4-yl)methylamine

Publications (1)

Publication Number Publication Date
CN104327065A true CN104327065A (en) 2015-02-04

Family

ID=52401884

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410464910.5A Pending CN104327065A (en) 2014-09-15 2014-09-15 Preparation method of N-methyl(quinolyl-4-yl)methylamine

Country Status (1)

Country Link
CN (1) CN104327065A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108285432A (en) * 2017-01-10 2018-07-17 湖南华腾制药有限公司 A kind of preparation method of quinoline

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120041A (en) * 1994-02-25 1996-04-10 阿迪尔公司 Novel benzobiulkyl, preparation of same and parmaceutical composition of same
JP2000204087A (en) * 1999-01-12 2000-07-25 Banyu Pharmaceut Co Ltd Inhibitor against geranylgeranyl transferase, i-type protein
CN1753672A (en) * 2002-12-24 2006-03-29 阿斯利康(瑞典)有限公司 4,5-diarylthiazole derivatives as cb-1 ligands
CN101213184A (en) * 2005-06-28 2008-07-02 塞诺菲-安万特股份有限公司 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
CN101263130A (en) * 2005-09-13 2008-09-10 詹森药业有限公司 2-aniline-4-aryl substituted thiazole derivatives
CN104311547A (en) * 2014-09-15 2015-01-28 湖南华腾制药有限公司 Preparation method of thiazole derivative

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120041A (en) * 1994-02-25 1996-04-10 阿迪尔公司 Novel benzobiulkyl, preparation of same and parmaceutical composition of same
JP2000204087A (en) * 1999-01-12 2000-07-25 Banyu Pharmaceut Co Ltd Inhibitor against geranylgeranyl transferase, i-type protein
CN1753672A (en) * 2002-12-24 2006-03-29 阿斯利康(瑞典)有限公司 4,5-diarylthiazole derivatives as cb-1 ligands
CN101213184A (en) * 2005-06-28 2008-07-02 塞诺菲-安万特股份有限公司 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
CN101263130A (en) * 2005-09-13 2008-09-10 詹森药业有限公司 2-aniline-4-aryl substituted thiazole derivatives
CN104311547A (en) * 2014-09-15 2015-01-28 湖南华腾制药有限公司 Preparation method of thiazole derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MUTHUPANDI NAGARAJ ET AL.: "copper(I)-catalyzed cascade sulfonimidate to sulfonamide rearrangement:synthesis of imidazo[1,2-a][1,4]diazepin-7(6h)-one", 《THE JOURNAL OF ORGANIC CHEMISTRY》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108285432A (en) * 2017-01-10 2018-07-17 湖南华腾制药有限公司 A kind of preparation method of quinoline

Similar Documents

Publication Publication Date Title
CN104262257A (en) Preparation method of pyrazole derivative
CN104926775A (en) Preparation method of fluorine-containing pyran derivative
CN104311547A (en) Preparation method of thiazole derivative
CN104311544A (en) Preparation method of benzoxazole derivative
CN104387367A (en) Method for preparing disubstituted benzimidazole derivative
CN104829581A (en) Preparation method of 6-bromo pyran derivative
CN104327065A (en) Preparation method of N-methyl(quinolyl-4-yl)methylamine
CN104844549A (en) Preparation method of 7 - bromine pyran derivatives
CN104829574A (en) 8-bromo pyran derivative preparation method
CN104829576A (en) Preparation method of 7-fluoropyran derivatives
CN104292143A (en) 2-(4-bromine benzyl) pyrrolidine preparation method
CN104211677A (en) Preparation method of anti hepatitis C drug intermediate
CN104262281A (en) Preparation method of 2-bromo-4(4-ethoxyphenyl) oxazole
CN105001117A (en) Method for synthesizing chlorine-containing azide compound
CN104326977A (en) Preparation method of 6,7-diethyl-4-hydroxyquinoline
CN105085510A (en) Preparation method of (S)-4-oxo-2-(thiazolidine-3-carbonyl) pyrrolidone-1-carboxylic acid tert-butyl ester
CN103724291A (en) Synthetic method of pramipexole dihydrochloride related substance B
CN104402880A (en) Preparation method of imidazopyridine derivative
CN104327029A (en) Preparation method of oxygen-containing heterocyclic compound
CN105218560B (en) The synthesis technique of the chlorothiophene of 7 bromine 4 simultaneously [3,2 D] pyrimidine
CN103319411A (en) Preparation method of imidafenacin
CN104292213A (en) Preparation method of pyrimidine derivative
CN104250233B (en) A kind of preparation method of 4-tertbutyloxycarbonyl-2-cyclopropyl morpholine
CN104592109A (en) Method for preparing 8-bromoquinoline derivative
CN105130841A (en) Preparation method of 3-iodophenyl azide compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150204

WD01 Invention patent application deemed withdrawn after publication